FDA inspection
Mylan Pharmaceuticals ULC: FDA inspection ending Jul 11, 2012
FDA inspection 791703 · No Action Indicated (NAI) · Etobicoke
Key facts
| Inspection ID | 791703 |
|---|---|
| Firm | Mylan Pharmaceuticals ULC |
| FEI number | 3002807060 |
| Address | 85 Advance Rd |
| City | Etobicoke |
| Country | Canada |
| Fiscal year | 2012 |
| Inspection end date | Jul 11, 2012 |
| Classification | No Action Indicated (NAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data